RSS

ELTP Elite Pharmaceuticals Inc

Last Post: 08/17/26
Followers: 77
Posts Today: 0
Views Today: 3246

ELTP Stock Quote & Tools

$0.2543 ▲ +0.0002 (+0.09%) As of Oct 16, 3:58 PM EDT
Last0.2543
$ Chg0.0002
Open0.2587
High0.2587
Beta0.3254
Year High0.690
Market Cap273.86M
P/B Ratio2.62
EPS0.06
Avg Vol (30d)781.7K
Volume509.6K
% Chg+0.09%
Prev Close0.2540
Low0.2400
VWAP0.24501
Year Low0.213
Total Shares1.08B
Shares Out1.08B
Float743.52M
ExchangeOTCQB
Healthcare Pharmaceuticals

ELTP Stock Message Board Discussion

  1. g2
  2. steges

Top 10 Most Recent News Articles

AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 21

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 17

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 27

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 25

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 14

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 28

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 28

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring Stock Buybacks: Unveiling Prominent Opportunities

Updated Category News Views 251

The Power of Share Buybacks Share buyback programs can significantly influence the stock market, but not all buybacks yield the same results. The effectiveness of these programs can depend largely on the scale of the repurchase relative to the company's overall market value. In this landscape, certain companies stand out for their substantial buyback capacities, which can...

Continue Reading
Exploring Global Ventures: A Journey of Dreams and Success

Updated Category News Views 150

From Yiwu to Overseas Success Lou Bingqiang, a remarkable figure from Yiwu, has spent over a decade expanding his horizons far beyond his hometown. For 14 years, he has been an integral part of the trade landscape in Peru, where he cultivated valuable relationships and grew as a successful entrepreneur. His fluency in Spanish has paved the way for smoother interactions...

Continue Reading
Exploring Top Dividend Stocks for Steady Income Growth

Updated Category News Views 67

Understanding Dividend Stocks Dividend stocks are a fantastic way to create a steady stream of passive income, gradually building wealth over time. In this article, we spotlight two prominent dividend stocks known for their impressive track records in returning value to investors through consistent and substantial dividends. Learn why these stocks are highly regarded for...

Continue Reading
Poland's WIG30 Index Climbs as Construction and Banking Shine

Updated Category News Views 146

Poland's Stock Market Shows Positive Trends Recently, Poland's stock market experienced a notable uptick, showcasing resilience amidst various economic factors. The WIG30 index, a key barometer of the Polish market, concluded the trading session on a positive note, climbing 1.37%. This shift can be attributed to strong performances in the construction, banking, and media...

Continue Reading
Everi Stock Surges to Record High, Catalyzed by Positive Trends

Updated Category News Views 233

Everi Stock Achieves New Heights in the Market Everi Holdings Inc. (NYSE: EVRI) has recently made headlines as its stock price soared to a remarkable 52-week high of $13.53. This surge indicates a strong bullish trend, fueled by robust investor confidence and an impressive gross profit margin of 80%. Over the past year, the growth in EVRI's stock value has been nothing...

Continue Reading